Is macrocytosis with a low RBC count a typical sign of vitamin B12 or folate deficiency?

Clinical presentation and diagnostic utility

• A hematologic pattern of high mean corpuscular volume (MCV > 100 fL, often exceeding 110–115 fL) and a low red blood cell (RBC) count is the classic clinical presentation of megaloblastic anemia due to vitamin B12 or folate deficiency.
• Despite being a key clinical indicator, macrocytosis lacks high sensitivity as up to 90% of functionally B12-deficient patients can present with a normal MCV. Additionally, coexisting microcytic conditions, such as iron deficiency, can normalize the MCV and mask the underlying deficiency, requiring confirmatory peripheral smears (to detect macro-ovalocytes and hypersegmented neutrophils) and metabolic panels (methylmalonic acid and homocysteine).

Molecular and cellular mechanisms

• Vitamin B12 and folate are essential for de novo thymidylate (dTMP) synthesis. A deficiency in B12 inactivates methionine synthase, trapping folate as 5-methyl-THF (the "methyl-folate trap") and depleting the 5,10-methylene-THF pool required by thymidylate synthase to convert dUMP to dTMP.
• This resulting thymidine starvation stalls DNA polymerase, causing S-phase cell-cycle arrest and halting nuclear maturation in developing bone marrow erythroblasts. Because cytoplasmic volume and hemoglobin synthesis continue uninterrupted, this nuclear-cytoplasmic asynchrony produces enlarged, immature megaloblasts.
• The majority of these defective, megaloblastic erythroblasts undergo apoptosis within the bone marrow. This accelerated intramedullary destruction (ineffective erythropoiesis) drastically reduces the release of mature red cells, leading to a low circulating RBC count alongside macrocytosis.

Bottom line

• Bottom line: Macrocytosis paired with a low RBC count is a classic hematologic signature of vitamin B12 or folate deficiency, directly caused by a methyl-folate trap and thymidine starvation that impair DNA synthesis, arrest the erythroblast cell cycle, and trigger ineffective erythropoiesis.